Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP61209.RA9e1n2OfeGw5sagbtTmacAiN5vTgcO0mf9ZVkHnhwjIk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP61209.RA9e1n2OfeGw5sagbtTmacAiN5vTgcO0mf9ZVkHnhwjIk130_assertion type Assertion NP61209.RA9e1n2OfeGw5sagbtTmacAiN5vTgcO0mf9ZVkHnhwjIk130_head.
- NP61209.RA9e1n2OfeGw5sagbtTmacAiN5vTgcO0mf9ZVkHnhwjIk130_assertion description "[The objective of this study was to explore combined effects of four candidate susceptibility genes and two exposures on Parkinson's disease (PD) risk; namely, alpha-synuclein (SNCA) promoter polymorphism REP1, microtubule-associated protein tau (MAPT) H1/H2 haplotypes, apolipoprotein E (APOE) epsilon2/epsilon3/epsilon4 polymorphism, ubiquitin carboxy-terminal esterase L1 (UCHL1) S18Y variant, cigarette smoking and caffeinated coffee consumption.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP61209.RA9e1n2OfeGw5sagbtTmacAiN5vTgcO0mf9ZVkHnhwjIk130_provenance.
- NP61209.RA9e1n2OfeGw5sagbtTmacAiN5vTgcO0mf9ZVkHnhwjIk130_assertion evidence source_evidence_literature NP61209.RA9e1n2OfeGw5sagbtTmacAiN5vTgcO0mf9ZVkHnhwjIk130_provenance.
- NP61209.RA9e1n2OfeGw5sagbtTmacAiN5vTgcO0mf9ZVkHnhwjIk130_assertion SIO_000772 18210157 NP61209.RA9e1n2OfeGw5sagbtTmacAiN5vTgcO0mf9ZVkHnhwjIk130_provenance.
- NP61209.RA9e1n2OfeGw5sagbtTmacAiN5vTgcO0mf9ZVkHnhwjIk130_assertion wasDerivedFrom gad-20130706 NP61209.RA9e1n2OfeGw5sagbtTmacAiN5vTgcO0mf9ZVkHnhwjIk130_provenance.
- NP61209.RA9e1n2OfeGw5sagbtTmacAiN5vTgcO0mf9ZVkHnhwjIk130_assertion wasGeneratedBy ECO_0000203 NP61209.RA9e1n2OfeGw5sagbtTmacAiN5vTgcO0mf9ZVkHnhwjIk130_provenance.